Daniel A Baur1,2, Harrison R Toney3, Michael J Saunders3, Katherine G Baur4, Nicholas D Luden3, Christopher J Womack3. 1. Department of Physical Education, Virginia Military Institute, 208 Cormack Hall, Lexington, VA, 24450, USA. baurda@vmi.edu. 2. Department of Exercise Science, Elon University, Elon, NC, 27244, USA. baurda@vmi.edu. 3. Department of Kinesiology, James Madison University, Harrisonburg, VA, 22801, USA. 4. Department of Physical Education, Virginia Military Institute, 208 Cormack Hall, Lexington, VA, 24450, USA.
Abstract
PURPOSE: This study examined the effects of a novel maltodextrin-fructose hydrogel supplement (MF-H) on cycling performance and gastrointestinal distress symptoms. METHODS: Nine endurance-trained male cyclists (age = 26.1 ± 6.6, mass = 80.9 ± 10.4 kg, VO2max = 55.5 ± 3.6 mL·kg·min-1) completed three experimental trials consisting of a 98-min varied-intensity cycling protocol followed by a performance test of ten consecutive sprint intervals. In a cross-over design, subjects consumed 250 mL of a treatment beverage every 15 min of cycling. Treatments consisted of 78 g·hr-1 of either (a) MF-H, (b) isocaloric maltodextrin-fructose (ratio-matched 2:1; MF), and (c) isocaloric maltodextrin only (MD). RESULTS: There were no differences in average sprint power between treatments (MF-H, 284 ± 51 W; MF, 281 ± 46 W; and MD, 277 ± 48 W), or power output for any individual sprint. Subjective ratings of gastrointestinal distress symptoms (nausea, fullness, and abdominal cramping) increased significantly over time during the cycling trials, but few individuals exceeded moderate levels in any trial with no systematic differences in gastrointestinal discomfort symptoms observed between treatments. CONCLUSIONS: In conclusion, ingestion of a maltodextrin/fructose hydrogel beverage during high-intensity cycling does not improve gastrointestinal comfort or performance compared to MF or MD beverages.
PURPOSE: This study examined the effects of a novel maltodextrin-fructose hydrogel supplement (MF-H) on cycling performance and gastrointestinal distress symptoms. METHODS: Nine endurance-trained male cyclists (age = 26.1 ± 6.6, mass = 80.9 ± 10.4 kg, VO2max = 55.5 ± 3.6 mL·kg·min-1) completed three experimental trials consisting of a 98-min varied-intensity cycling protocol followed by a performance test of ten consecutive sprint intervals. In a cross-over design, subjects consumed 250 mL of a treatment beverage every 15 min of cycling. Treatments consisted of 78 g·hr-1 of either (a) MF-H, (b) isocaloric maltodextrin-fructose (ratio-matched 2:1; MF), and (c) isocaloric maltodextrin only (MD). RESULTS: There were no differences in average sprint power between treatments (MF-H, 284 ± 51 W; MF, 281 ± 46 W; and MD, 277 ± 48 W), or power output for any individual sprint. Subjective ratings of gastrointestinal distress symptoms (nausea, fullness, and abdominal cramping) increased significantly over time during the cycling trials, but few individuals exceeded moderate levels in any trial with no systematic differences in gastrointestinal discomfort symptoms observed between treatments. CONCLUSIONS: In conclusion, ingestion of a maltodextrin/fructose hydrogel beverage during high-intensity cycling does not improve gastrointestinal comfort or performance compared to MF or MD beverages.
Authors: H P Peters; F W van Schelven; P A Verstappen; R W de Boer; E Bol; W B Erich; C R van der Togt; W R de Vries Journal: Med Sci Sports Exerc Date: 1993-11 Impact factor: 5.411
Authors: Daniel A Baur; Adam B Schroer; Nicholas D Luden; Christopher J Womack; Sarah A Smyth; Michael J Saunders Journal: Med Sci Sports Exerc Date: 2014-09 Impact factor: 5.411
Authors: Gareth A Wallis; David S Rowlands; Christopher Shaw; Roy L P G Jentjens; Asker E Jeukendrup Journal: Med Sci Sports Exerc Date: 2005-03 Impact factor: 5.411
Authors: Beate Pfeiffer; Alexandra Cotterill; Dominik Grathwohl; Trent Stellingwerff; Asker E Jeukendrup Journal: Int J Sport Nutr Exerc Metab Date: 2009-10 Impact factor: 4.599
Authors: Andy J King; John P O'Hara; Nicola C Arjomandkhah; Josh Rowe; Douglas J Morrison; Thomas Preston; Roderick F G J King Journal: Eur J Appl Physiol Date: 2019-03-06 Impact factor: 3.078
Authors: Daniel A Baur; Fernanda de C S Vargas; Christopher W Bach; Jordan A Garvey; Michael J Ormsbee Journal: Nutrients Date: 2016-06-25 Impact factor: 5.717